Proton Partial Stereotactic Ablative Boost Radiotherapy Delivered Higher BED in Large NSCLC

被引：0
|
作者：
Bai, Y. [1 ]
Gao, X. [1 ]
Ma, M. [1 ]
Ren, X. Y. [2 ]
机构：
[1] Peking Univ, Hosp 1, Dept Radiat Oncol, Beijing, Peoples R China
[2] Peking Univ, Hosp 1, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.947
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3630
引用
收藏
页码：E698 / E699
页数：2
相关论文
共 50 条
  • [1] Partial Stereotactic Ablative Boost Radiation Therapy In Bulky NSCLC
    Bai, Y.
    Gao, X.
    Qin, S.
    Chen, J.
    Su, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E673 - E673
  • [2] Partial Stereotactic Ablative Boost Radiotherapy for Bulky Lung Cancer
    Bai, Y.
    Gao, X.
    Qin, S.
    Ma, M.
    Chen, J.
    Liu, S.
    Gao, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E361 - E362
  • [3] STEREOTACTIC ABLATIVE RADIOTHERAPY IN EARLY STAGE NSCLC
    Senan, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] Neoadjuvant Stereotactic Ablative and Hypofractionated Radiotherapy for Oligometastatic NSCLC
    Newman, N. B.
    Anderson, J. L.
    Shinohara, E. T.
    Michael, P.
    Attia, A.
    Osmundson, E. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1196 - 1196
  • [5] Stereotactic ablative radiotherapy for inoperable stage I NSCLC
    Andratschke, Nicolaus
    LANCET ONCOLOGY, 2012, 13 (08): : 746 - 748
  • [6] Partial Stereotactic Ablative Radiotherapy Boost before Conventional Radiotherapy (P-SABR) for Large (> 5 cm) Unresectable Soft Tissue Sarcoma
    Bai, Y.
    Gao, X.
    Qin, S.
    Li, S.
    Ma, M.
    Liu, S.
    Gao, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E428 - E428
  • [7] Preliminary Study on Immunological Mechanism of Partial Stereotactic Ablative Boost Radiotherapy (P-SABR)
    Li, S.
    Bai, Y.
    Gao, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E380 - E380
  • [8] Clinical implementation of stereotactic ablative radiotherapy (SABR) for NSCLC in the UK
    Baker, A.
    Clark, C.
    Ciurlionis, L.
    Distefano, G.
    Hatton, M.
    Jain, P.
    Lilley, J.
    Mayles, H.
    Miles, E.
    Scott, A.
    Webster, G.
    LUNG CANCER, 2013, 79 : S61 - S61
  • [9] ROLE OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN STAGE I NSCLC
    Slotman, Ben
    Lagerwaard, Frank
    Haasbeek, Niels
    Verstegen, Naomi
    Dahele, Max
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S103 - S103
  • [10] The Clinical Outcomes And Dosimetric Analysis Of Partial Stereotactic Ablative Boost Radiotherapy In Bulky Urinary Tract Malignancy
    Chen, J.
    Gao, X. S.
    Bai, Y.
    Qin, S.
    Li, H.
    Ma, M.
    Wang, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E900 - E901
12345